SEARCH

SEARCH BY CITATION

In February 2006, the International Consensus Conference on Intraperitoneal Chemotherapy in Ovarian Cancer Patients in provided the first worldwide consensus after the National Cancer Institute issued an announcement encouraging the treatment of advanced ovarian cancer with anticancer drugs after surgery, including intraperitoneal (IP) therapy. At that conference, a consensus was obtained on important questions regarding the standard of care in IP therapy for patients with ovarian cancer.